Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

NCT00224315 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.

NCT NCT00224315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00224315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
Lead sponsor
Central Institute of Mental Health, Mannheim
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2003
Completion date
September 30, 2006
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, schizoaffective disorder